A research study with the goal of finding a new treatment for Alzheimer’s disease is moving into Stage 2 of the trial.

Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...

In searching for a possible therapeutic target to stop the progress of this disease, an international scientific team, led by ...

For many years, astrocytes were seen as simple support cells in the brain. Today, that picture is changing fast.

Scientists at the USC Leonard Davis School of Gerontology have discovered a key connection between high levels of iron in the ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

A major global study tested whether European-derived polygenic risk scores (PGS) for Alzheimer’s disease can predict risk ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

One of the most common genes associated with Alzheimer's has now been linked to loss of smell. The discovery may offer a new ...

But in a surprise twist, recent research published by my colleagues and me has found that a protein from Helicobacter pylori ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...